Hypoxia‑induced internalization of connexin 26 and connexin 43 in pulmonary epithelial cells is involved in the occurrence of non‑small cell lung cancer via the P53/MDM2 signaling pathway Corrigendum in /10.3892/ijo.2019.4906

Zeng,Shang‑Gan; Lin,Xiang; Liu,Ji‑Chun; Zhou,Jing

doi:10.3892/ijo.2019.4867

Hypoxia‑induced internalization of connexin 26 and connexin 43 in pulmonary epithelial cells is involved in the occurrence of non‑small cell lung cancer via the P53/MDM2 signaling pathway

Corrigendum in: /10.3892/ijo.2019.4906

Authors:
- Shang‑Gan Zeng
- Xiang Lin
- Ji‑Chun Liu
- Jing Zhou
View Affiliations

Affiliations: Department of Thoracic Surgery, The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi 330006, P.R. China, Departments of Cardio‑Thoracic Surgery, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi 330006, P.R. China, Department of Respiratory, The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi 330006, P.R. China
Published online on: September 3, 2019 https://doi.org/10.3892/ijo.2019.4867
Pages: 845-859
Copyright: © Zeng et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Reports have highlighted an association between connexins (CXs) or gap junction proteins and non‑small cell lung cancer (NSCLC). In the present study, it was aimed to elucidate the regulatory mechanism of CX26 and CX43 under hypoxic conditions in NSCLC. Clinical samples were collected for analysis of CX26 and CX43 expression and clinical cancerization followed by quantification of CX26 and CX43 expression. Following the establishment of an in vitro hypoxia model, P53/murine double minute‑2 (MDM2) signaling pathway‑, proliferation‑ and epithelial‑mesenchymal transition (EMT)‑related genes were quantified to evaluate the influence of CX26 and CX43 on the biological functions of pulmonary epithelial cells in NSCLC. In addition, the proliferation and tumorigenicity of cancer cells were assessed by EdU staining and xenograft tumors, respectively. Decreased expression of CX26 and CX43 was found in cancer tissues compared with surrounding normal tissue. Hypoxia was shown to activate the P53/MDM2 axis and stimulate the downregulation, ubiquitination and degradation of CX26 and CX43, which were translocated from the membrane to the cytoplasm. Low levels of CX26 and CX43 were demonstrated to further promote EMT and the induction of the proliferation and tumorigenicity of cancer cells. These results were reflected by decreased E‑cadherin expression and increased N‑cadherin expression, along with increased cell migration, promoted cell proliferation ability and elevated relative protein expression of Oct4 and Nanog, and accelerated tumor growth, accompanied by a higher number of metastatic nodes. Taken together, the key observations of the present study demonstrate that the internalization of CX26 and CX43 promoted proliferation, EMT and migration and thus induced NSCLC via aberrant activation of the P53/MDM2 signaling pathway under hypoxic conditions.

View Figures

View References

1	Siegel RL, Miller KD and Jemal A: Cancer statistics, 2019. CA Cancer J Clin. 69:7–34. 2019. View Article : Google Scholar : PubMed/NCBI
2	Wakelee H, Kelly K and Edelman MJ: 50 Years of progress in the systemic therapy of non-small cell lung cancer. Am Soc Clin Oncol Educ Book. pp. 177–189. 2014, View Article : Google Scholar
3	Lei Z, Xu G, Wang L, Yang H, Liu X, Zhao J and Zhang HT: MiR-142-3p represses TGF-β-induced growth inhibition through repression of TGFbetaR1 in non-small cell lung cancer. FASEB J. 28:2696–2704. 2014. View Article : Google Scholar : PubMed/NCBI
4	Grutsch JF, Wood PA, Du-Quiton J, Reynolds JL, Lis CG, Levin RD, Ann Daehler M, Gupta D, Quiton DF and Hrushesky WJ: Validation of actigraphy to assess circadian organization and sleep quality in patients with advanced lung cancer. J Circadian Rhythms. 9:42011. View Article : Google Scholar : PubMed/NCBI
5	Kleisiaris CF, Kritsotakis EI, Daniil Z, Tzanakis N, Papaioannou A and Gourgoulianis KI: The prevalence of obstructive sleep apnea-hypopnea syndrome-related symptoms and their relation to airflow limitation in an elderly population receiving home care. Int J Chron Obstruct Pulmon Dis. 9:1111–1117. 2014. View Article : Google Scholar : PubMed/NCBI
6	Bouloukaki I, Papadimitriou V, Sofras F, Mermigkis C, Moniaki V, Siafakas NM and Schiza SE: Abnormal cytokine profile in patients with obstructive sleep apnea-hypopnea syndrome and erectile dysfunction. Mediators Inflamm. 2014:5689512014. View Article : Google Scholar : PubMed/NCBI
7	Yang J, Qin G, Luo M, Chen J, Zhang Q, Li L, Pan L and Qin S: Reciprocal positive regulation between Cx26 and PI3K/Akt pathway confers acquired gefitinib resistance in NSCLC cells via GJIC-independent induction of EMT. Cell Death Dis. 6:e18292015. View Article : Google Scholar : PubMed/NCBI
8	Crespin S, Bacchetta M, Bou Saab J, Tantilipikorn P, Bellec J, Dudez T, Nguyen TH, Kwak BR, Lacroix JS, Huang S, et al: Cx26 regulates proliferation of repairing basal airway epithelial cells. Int J Biochem Cell Biol. 52:152–160. 2014. View Article : Google Scholar : PubMed/NCBI
9	Garcia IE, Maripillán J, Jara O, Ceriani R, Palacios-Munoz A, Ramachandran J, Olivero P, Perez-Acle T, González C, Sáez JC, et al: Keratitis-ichthyosis-deafness syndrome-associated Cx26 mutants produce nonfunctional gap junctions but hyperactive hemichannels when co-expressed with wild type Cx43. J Invest Dermatol. 135:1338–1347. 2015. View Article : Google Scholar : PubMed/NCBI
10	Sulkowska U, Febp AW and Sulkowski S: Association of STAT3 with Cx26 and Cx43 in human uterine endometrioid adenocarcinoma. Oncol Lett. 11:4134–4138. 2016. View Article : Google Scholar : PubMed/NCBI
11	Deben C, Wouters A, Op de Beeck K, van Den Bossche J, Jacobs J, Zwaenepoel K, Peeters M, Van Meerbeeck J, Lardon F, Rolfo C, et al: The MDM2-inhibitor Nutlin-3 synergizes with cisplatin to induce p53 dependent tumor cell apoptosis in non-small cell lung cancer. Oncotarget. 6:22666–22679. 2015. View Article : Google Scholar : PubMed/NCBI
12	Chang H, Li C, Huo K, Wang Q, Lu L, Zhang Q, Wang Y and Wang W: Luteolin prevents H2O2-induced apoptosis in H9C2 cells through modulating Akt-P53/Mdm2 signaling pathway. Biomed Res Int. 2016:51258362016. View Article : Google Scholar : PubMed/NCBI
13	Reddy R, Buckley S, Doerken M, Barsky L, Weinberg K, Anderson KD, Warburton D and Driscoll B: Isolation of a putative progenitor subpopulation of alveolar epithelial type 2 cells. Am J Physiol Lung Cell Mol Physiol. 286:L658–L667. 2004. View Article : Google Scholar
14	Bao B, Groves K, Zhang J, Handy E, Kennedy P, Cuneo G, Supuran CT, Yared W, Rajopadhye M and Peterson JD: In vivo imaging and quantification of carbonic anhydrase IX expression as an endogenous biomarker of tumor hypoxia. PLoS One. 7:e508602012. View Article : Google Scholar : PubMed/NCBI
15	Tang D, Yan T, Zhang J, Jiang X, Zhang D and Huang Y: Notch1 signaling contributes to hypoxia-induced high expression of Integrin β1 in keratinocyte migration. Sci Rep. 7:439262017. View Article : Google Scholar
16	Hau S, Reich DM, Scholz M, Naumann W, Emmrich F, Kamprad M and Boltze J: Evidence for neuroprotective properties of human umbilical cord blood cells after neuronal hypoxia in vitro. BMC Neurosci. 9:302008. View Article : Google Scholar : PubMed/NCBI
17	Bouley R, Lin HY, Raychowdhury MK, Marshansky V, Brown D and Ausiello DA: Downregulation of the vasopressin type 2 receptor after vasopressin-induced internalization: Involvement of a lysosomal degradation pathway. Am J Physiol Cell Physiol. 288:C1390–C1401. 2005. View Article : Google Scholar : PubMed/NCBI
18	Kim SJ, Kim MY, Lee EJ, Ahn YS and Baik JH: Distinct regulation of internalization and mitogen-activated protein kinase activation by two isoforms of the dopamine D2 receptor. Mol Endocrinol. 18:640–652. 2004. View Article : Google Scholar
19	Atkins D, Reiffen KA, Tegtmeier CL, Winther H, Bonato MS and Storkel S: Immunohistochemical detection of EGFR in paraffin-embedded tumor tissues: Variation in staining intensity due to choice of fixative and storage time of tissue sections. J Histochem Cytochem. 52:893–901. 2004. View Article : Google Scholar : PubMed/NCBI
20	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar
21	Wilmanns C, Fan D, O'Brian CA, Bucana CD and Fidler IJ: Orthotopic and ectopic organ environments differentially influence the sensitivity of murine colon carcinoma cells to doxorubicin and 5-fluorouracil. Int J Cancer. 52:98–104. 1992. View Article : Google Scholar : PubMed/NCBI
22	Schlagbauer-Wadl H, Griffioen M, van Elsas A, Schrier PI, Pustelnik T, Eichler HG, Wolff K, Pehamberger H and Jansen B: Influence of increased c-Myc expression on the growth characteristics of human melanoma. J Invest Dermatol. 112:332–336. 1999. View Article : Google Scholar : PubMed/NCBI
23	Hong QY, Wu GM, Qian GS, Hu CP, Zhou JY, Chen LA, Li WM, Li SY, Wang K, Wang Q, et al: Prevention and management of lung cancer in China. Cancer. 121(Suppl 17): S3080–S3088. 2015. View Article : Google Scholar
24	Long F, Su JH, Liang B, Su LL and Jiang SJ: Identification of gene biomarkers for distinguishing small-cell lung cancer from non-small-cell lung cancer using a network-based approach. Biomed Res Int. 2015:6853032015. View Article : Google Scholar : PubMed/NCBI
25	Olmeda B, Umstead TM, Silveyra P, Pascual A, Lopez-Barneo J, Phelps DS, Floros J and Perez-Gil J: Effect of hypoxia on lung gene expression and proteomic profile: Insights into the pulmonary surfactant response. J Proteomics. 101:179–191. 2014. View Article : Google Scholar : PubMed/NCBI
26	Teleki I, Szasz AM, Maros ME, Gyorffy B, Kulka J, Meggyeshazi N, Kiszner G, Balla P, Samu A and Krenacs T: Correlations of differentially expressed gap junction connexins Cx26, Cx30, Cx32, Cx43 and Cx46 with breast cancer progression and prognosis. PLoS One. 9:e1125412014. View Article : Google Scholar : PubMed/NCBI
27	Losa D, Chanson M and Crespin S: Connexins as therapeutic targets in lung disease. Expert Opin Ther Targets. 15:989–1002. 2011. View Article : Google Scholar : PubMed/NCBI
28	Liu T, Li Y, Zhang B, Ma L, Liu W, Li Z and Jin F: The role of phosphorylated Cx43 on PKC mediated Ser368 in lung injury induced by seawater inhalation. Inflammation. 38:1847–1854. 2015. View Article : Google Scholar : PubMed/NCBI
29	Lin J, Huang H, Lv G, Xu X, Lin W, Xu X, Cheng J and Zheng M: Chronic prenatal hypoxia impairs cochlear development, a mechanism involving connexin26 expression and promoter methylation. Int J Mol Med. 41:852–858. 2018.
30	Wu X, Huang W, Luo G and Alain LA: Hypoxia induces connexin 43 dysregulation by modulating matrix metalloproteinases via MAPK signaling. Mol Cell Biochem. 384:155–162. 2013. View Article : Google Scholar : PubMed/NCBI
31	Otto T, Gellhaus A, Lüschen N, Scheidler J, Bendix I, Dunk C, Wolf N, Lennartz K, Koninger A, Schmidt M, et al: Oxygen sensitivity of placental trophoblast Connexins 43 and 46: A role in preeclampsia? J Cell Biochem. 116:2924–2937. 2015. View Article : Google Scholar : PubMed/NCBI
32	Morrow JK, Lin HK, Sun SC and Zhang S: Targeting ubiquitination for cancer therapies. Future Med Chem. 7:2333–2350. 2015. View Article : Google Scholar : PubMed/NCBI
33	Falk MM, Kells RM and Berthoud VM: Degradation of connexins and gap junctions. FEBS Lett. 588:1221–1229. 2014. View Article : Google Scholar : PubMed/NCBI
34	Zhao JQ, Sun FJ, Liu SS, Yang J, Wu YQ, Li GS, Chen QY and Wang JX: Expression of connexin 43 and E-cadherin protein and mRNA in non-small cell lung cancers in Chinese patients. Asian Pac J Cancer Prev. 14:639–643. 2013. View Article : Google Scholar : PubMed/NCBI
35	Chiou SH, Wang ML, Chou YT, Chen CJ, Hong CF, Hsieh WJ, Chang HT, Chen YS, Lin TW, Hsu HS and Wu CW: Coexpression of Oct4 and Nanog enhances malignancy in lung adenocarcinoma by inducing cancer stem cell-like properties and epithelial-mesenchymal transdifferentiation. Cancer Res. 70:10433–10444. 2010. View Article : Google Scholar : PubMed/NCBI
36	Wang W and Hu Y: Small molecule agents targeting the p53-MDM2 pathway for cancer therapy. Med Res Rev. 32:1159–1196. 2012. View Article : Google Scholar : PubMed/NCBI
37	Zhang P, Kratz AS, Salama M, Elabd S, Heinrich T, Wittbrodt J, Blattner C and Davidson G: Expression screening using a Medaka cDNA library identifies evolutionarily conserved regulators of the p53/Mdm2 pathway. BMC Biotechnol. 15:922015. View Article : Google Scholar : PubMed/NCBI